rs1377470
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002576.5(PAK1):c.1116+977T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.314 in 151,908 control chromosomes in the GnomAD database, including 7,657 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.31 ( 7657 hom., cov: 31)
Consequence
PAK1
NM_002576.5 intron
NM_002576.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.764
Publications
12 publications found
Genes affected
PAK1 (HGNC:8590): (p21 (RAC1) activated kinase 1) This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Mutations in this gene have been associated with macrocephaly, seizures, and speech delay. Overexpression of this gene is also reported in many cancer types, and particularly in breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]
PAK1 Gene-Disease associations (from GenCC):
- intellectual developmental disorder with macrocephaly, seizures, and speech delayInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAK1 | NM_002576.5 | c.1116+977T>G | intron_variant | Intron 11 of 14 | ENST00000356341.8 | NP_002567.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.314 AC: 47647AN: 151788Hom.: 7657 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
47647
AN:
151788
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.314 AC: 47661AN: 151908Hom.: 7657 Cov.: 31 AF XY: 0.310 AC XY: 23034AN XY: 74256 show subpopulations
GnomAD4 genome
AF:
AC:
47661
AN:
151908
Hom.:
Cov.:
31
AF XY:
AC XY:
23034
AN XY:
74256
show subpopulations
African (AFR)
AF:
AC:
12804
AN:
41454
American (AMR)
AF:
AC:
3751
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
1188
AN:
3466
East Asian (EAS)
AF:
AC:
1129
AN:
5156
South Asian (SAS)
AF:
AC:
2187
AN:
4806
European-Finnish (FIN)
AF:
AC:
2836
AN:
10560
Middle Eastern (MID)
AF:
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22743
AN:
67888
Other (OTH)
AF:
AC:
662
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1642
3285
4927
6570
8212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1236
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.